Alexion Pharmaceuticals Inc (ALXN)-Financial and Strategic SWOT Analysis Review
May 2017
60
About the Report
About the Report
Alexion Pharmaceuticals Inc (ALXN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Alexion Pharmaceuticals Inc (Alexion) focuses on developing and delivering life-changing drug therapies for patients with serious and ultra-rare disorders. The company develops biologic therapeutic products for the treatment of severe disease states, including genetic diseases, hematologic diseases, cancer, neurological, and autoimmune disorders. The company's marketed product portfolio includes Soliris (eculizumab) used for two indications paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (AHUS); Strensiq (asfotase alfa) for the treatment of hypophosphatasia (HPP)and Kanuma (sebelipase alfa) for the treatment of Lysosomal Acid Lipase Deficiency (LAL Deficiency or LAL-D). The company's research and development focuses on developing its lead product Soliris, for various other serious disease states. It also has other candidates in development targeting rare metabolic and inflammatory disorders. Alexion is headquartered in New Haven, Connecticut, the US.
Alexion Pharmaceuticals Inc Key Recent Developments
Apr 27,2017: Alexion Reports First Quarter 2017 Results
Mar 27,2017: Alexion Appoints Ludwig Hantson, Ph.D., As Chief Executive Officer
Mar 02,2017: Leonard Bell, M.D., Alexion's Founder, Announces Plans to Retire as Chairman and Board Member
Feb 16,2017: Alexion Reports Fourth Quarter And Full Year 2016 Results And Provides Financial Guidance For 2017
Jan 04,2017: Alexion Pharmaceuticals Files Form 10-Q for Third Quarter 2016
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Alexion Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1-About the Company 6
Alexion Pharmaceuticals Inc-Key Facts 6
Alexion Pharmaceuticals Inc-Key Employees 7
Alexion Pharmaceuticals Inc-Key Employee Biographies 8
Alexion Pharmaceuticals Inc-Major Products and Services 9
Alexion Pharmaceuticals Inc-Pharmaceutical Pipeline Products Data 10
Alexion Pharmaceuticals Inc, Pipeline Products by Therapy Area 10
Alexion Pharmaceuticals Inc, Pipeline Products by Development Phase 11
Alexion Pharmaceuticals Inc-History 12
Alexion Pharmaceuticals Inc-Company Statement 16
Alexion Pharmaceuticals Inc-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Section 2-Company Analysis 21
Alexion Pharmaceuticals Inc-Business Description 21
Alexion Pharmaceuticals Inc-Corporate Strategy 22
Alexion Pharmaceuticals Inc-SWOT Analysis 23
SWOT Analysis-Overview 23
Alexion Pharmaceuticals Inc-Strengths 23
Alexion Pharmaceuticals Inc-Weaknesses 24
Alexion Pharmaceuticals Inc-Opportunities 25
Alexion Pharmaceuticals Inc-Threats 26
Alexion Pharmaceuticals Inc-Key Competitors 27
Section 3-Company Financial Ratios 28
Financial Ratios-Capital Market Ratios 28
Financial Ratios-Annual Ratios 29
Performance Chart 32
Financial Performance 32
Financial Ratios-Interim Ratios 33
Financial Ratios-Ratio Charts 34
Section 4-Company's Lifesciences Financial Deals and Alliances 35
Alexion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 35
Alexion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 36
Alexion Pharmaceuticals Inc, Recent Deals Summary 37
Section 5-Company's Recent Developments 38
Apr 27, 2017: Alexion Reports First Quarter 2017 Results 38
Mar 27, 2017: Alexion Appoints Ludwig Hantson, Ph.D., As Chief Executive Officer 40
Mar 02, 2017: Leonard Bell, M.D., Alexion's Founder, Announces Plans to Retire as Chairman and Board Member 41
Feb 16, 2017: Alexion Reports Fourth Quarter And Full Year 2016 Results And Provides Financial Guidance For 2017 42
Jan 04, 2017: Alexion Pharmaceuticals Files Form 10-Q for Third Quarter 2016 44
Dec 12, 2016: Alexion Pharmaceuticals appoints interim CEO 46
Dec 12, 2016: Alexion's Board Of Directors Announces New Leadership Appointments 48
Oct 27, 2016: Alexion Reports Third Quarter 2016 Results 50
Oct 18, 2016: The Leukemia & Lymphoma Society Launches Groundbreaking Precision Medicine Approach to Treat Acute Myeloid Leukemia, One of the Deadliest Blood Cancers 52
Jul 28, 2016: Alexion Reports Second Quarter 2016 Results 54
Section 6-Appendix 56
Methodology 56
Ratio Definitions 56
About GlobalData 60
Contact Us 60
Disclaimer 60
List of Figure
List of Figures
Alexion Pharmaceuticals Inc, Pipeline Products by Therapy Area 10
Alexion Pharmaceuticals Inc, Pipeline Products by Development Phase 11
Alexion Pharmaceuticals Inc, Performance Chart (2012-2016) 32
Alexion Pharmaceuticals Inc, Ratio Charts 34
Alexion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 35
Alexion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 36
List of Table
List of Tables
Alexion Pharmaceuticals Inc, Key Facts 6
Alexion Pharmaceuticals Inc, Key Employees 7
Alexion Pharmaceuticals Inc, Key Employee Biographies 8
Alexion Pharmaceuticals Inc, Major Products and Services 9
Alexion Pharmaceuticals Inc, Number of Pipeline Products by Therapy Area 10
Alexion Pharmaceuticals Inc, Number of Pipeline Products by Development Stage 11
Alexion Pharmaceuticals Inc, History 12
Alexion Pharmaceuticals Inc, Subsidiaries 18
Alexion Pharmaceuticals Inc, Key Competitors 27
Alexion Pharmaceuticals Inc, Ratios based on current share price 28
Alexion Pharmaceuticals Inc, Annual Ratios 29
Alexion Pharmaceuticals Inc, Annual Ratios (Cont...1) 30
Alexion Pharmaceuticals Inc, Annual Ratios (Cont...2) 31
Alexion Pharmaceuticals Inc, Interim Ratios 33
Alexion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 35
Alexion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 36
Alexion Pharmaceuticals Inc, Recent Deals Summary 37
Currency Codes 56
Capital Market Ratios 56
Equity Ratios 57
Profitability Ratios 57
Cost Ratios 58
Liquidity Ratios 58
Leverage Ratios 59
Efficiency Ratios 59
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.